Tenecteplase for treatment of acute myocardial infarction

OBJECTIVE: To describe the pharmacology, pharmacokinetics, efficacy, and safety of tenecteplase in reducing mortality associated with acute myocardial infarction (AMI). DATA SOURCES: Published articles were identified from MEDLINE (from 1966 to December 2000) and Current Contents (all sections) sear...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Annals of pharmacotherapy 2001-10, Vol.35 (10), p.1233-1240
Hauptverfasser:	Turcasso, NM, Nappi, JM
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Clinical Trials as Topic Fibrinolytic Agents - adverse effects Fibrinolytic Agents - pharmacokinetics Fibrinolytic Agents - therapeutic use Formularies as Topic Half-Life Humans Intracranial Hemorrhages - chemically induced Medical sciences Middle Aged Myocardial Infarction - drug therapy Pharmacology. Drug treatments Tissue Distribution Tissue Plasminogen Activator - adverse effects Tissue Plasminogen Activator - pharmacokinetics Tissue Plasminogen Activator - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!